Essential core activities III
Active Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,555,875
Award facts
- Contract value 74% obligated
-
- $1,555,875.00 Current, with exercised options
- $2,099,764.00 Potential, with all options
- Completion date 78% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $329,899 | |
| Funding Only Action | $179,598 | |
| Funding Only Action | $333,464 | |
| Original award | $712,914 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 10, 2017, with a ceiling value of $2,099,764 for preclinical development support under the Essential Core Activities III program.
Place of performance is Rockville, MD. The order is priced as cost-plus-fixed-fee and runs through June 8, 2029. Advanced Bioscience Laboratories provides contract research and manufacturing services specializing in gene therapies, vaccines, oncolytics, and immunotherapies, supporting NIAID's infectious disease research and product development initiatives.
In fiscal 2024, the order invoiced $96 thousand across 0.1 FTEs and 232 contractor hours, reflecting a derived government-paid rate of $414.81 per hour. The awardee self-performed all reported labor with no subcontractors.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 10, 2017.
How much is contract 75N93024F00001 worth?
The government has obligated $1,555,875 on 75N93024F00001. Its potential value, with all options, is $2,099,764.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award